These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9095173)

  • 1. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.
    Klein KA; Reiter RE; Redula J; Moradi H; Zhu XL; Brothman AR; Lamb DJ; Marcelli M; Belldegrun A; Witte ON; Sawyers CL
    Nat Med; 1997 Apr; 3(4):402-8. PubMed ID: 9095173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
    Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations.
    Zhou JR; Yu L; Zerbini LF; Libermann TA; Blackburn GL
    Int J Cancer; 2004 Jul; 110(6):800-6. PubMed ID: 15170660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.
    Craft N; Shostak Y; Carey M; Sawyers CL
    Nat Med; 1999 Mar; 5(3):280-5. PubMed ID: 10086382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2-activated lymphocytes in scid mice.
    Lubaroff DM; Cohen MB; Schultz LD; Beamer WG
    Prostate; 1995 Jul; 27(1):32-41. PubMed ID: 7541529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting.
    Nguyen HM; Corey E
    Methods Mol Biol; 2011; 776():295-312. PubMed ID: 21796533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a SCID mouse model to select for a more aggressive strain of prostate cancer.
    Davies MR; Lee YP; Lee C; Zhang X; Afar DE; Lieberman JR
    Anticancer Res; 2003; 23(3B):2245-52. PubMed ID: 12894499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
    Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
    Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
    McCulloch DR; Opeskin K; Thompson EW; Williams ED
    Prostate; 2005 Sep; 65(1):35-43. PubMed ID: 15800936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of seven new human prostate tumor xenograft models and their histopathological characterization.
    van Weerden WM; de Ridder CM; Verdaasdonk CL; Romijn JC; van der Kwast TH; Schröder FH; van Steenbrugge GJ
    Am J Pathol; 1996 Sep; 149(3):1055-62. PubMed ID: 8780407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
    Li ZG; Mathew P; Yang J; Starbuck MW; Zurita AJ; Liu J; Sikes C; Multani AS; Efstathiou E; Lopez A; Wang J; Fanning TV; Prieto VG; Kundra V; Vazquez ES; Troncoso P; Raymond AK; Logothetis CJ; Lin SH; Maity S; Navone NM
    J Clin Invest; 2008 Aug; 118(8):2697-710. PubMed ID: 18618013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
    Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
    Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer.
    Plymate SR; Haugk K; Coleman I; Woodke L; Vessella R; Nelson P; Montgomery RB; Ludwig DL; Wu JD
    Clin Cancer Res; 2007 Nov; 13(21):6429-39. PubMed ID: 17975155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.
    Craft N; Chhor C; Tran C; Belldegrun A; DeKernion J; Witte ON; Said J; Reiter RE; Sawyers CL
    Cancer Res; 1999 Oct; 59(19):5030-6. PubMed ID: 10519419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.